Meta-edc

Latest version: v0.3.14

Safety actively analyzes 624049 Python packages for vulnerabilities to keep your Python projects secure.

Scan your dependencies

Page 7 of 10

0.1.81

------
- add eGFR notification for a creatinine that calcs to a 20% drop
in eGFR from baseline
- add CRF status to each CRF
- fix issues with eligibility allow invalid OGTT, refactor
eligibility calc in Eligibility class
- only call eligibility class in save method - once
- reuse display label as func instead of calling entire class
- add PII group to pharmacists
- separate offschedule forms from End of Study form. Update action
itens to only create EOS action after Offschedule forms are added.
- remove EOS phase 2 code
- check not on any schedule before allowing EOS submit
- add detail to reasons ineligible key/value pairs
- fix issue with pregnancy workflow
- add additional questions to screening
- part 2: only accept appt date if patient agrees to P3
- part 2/3: ask for contact number, indicate patient will not
return after several attemps
- always allow P3 regardless of LTFU report in P2 (see signal)
- get appt date for repeat GLU
- add additional filters and columns to changelist for
subjectscreening with links to screen and subject
listboards/dashboards
- add date from HBA1C on screening form
- use protocol incident model mixin instead of protocol violation
model mixin. Mostly changes choices and form validator
- remove admin and form for original HE CRF
- update forms reference
- add canned views as a requirement
- update build
- bump edc
- change VL from 6m to within 12m
- fix pill count eval as int on medication adherence
- incorporate changes to pharmacy prescriptions and refills
- management command to create missing rx
- change 1010 lower from 15 to 10 days
- refactor from edc-blood-results to edc-lab-results

0.1.80

------
- minor fix to HE form validator

0.1.77

---------------
- add pregnancy, delivery, birth outcomes
- add repeat glucose tests in screening part three
- BMI normal range (5-60)
- remove all conditional statements for PHASE2
- remove sarscov2 requirement
- remove PHASE2 randomizer
- remove PHAS2 only tests
- add part three report datetime to form
- change fasting blood glucose field prefix from `ifg` to `fbg`
- add <400 in last 6m question to P3 screening
- add migrations

0.1.76

------
- set week 2 lower bound to 3 days in window period
- rename euro-qol auth groups in auths.py
- rename rando groups in auths.py
- add meta_pharmacy app
- missing prescriptions management command
- add StudyMedicationForm
- create prescription in signal on consent post-save
- update offstudy reasons in list_data.py
- populate static pharmacy models in signal (apps.py)
- separate admin class for Phase 3 EoS
- update phase 3 withdrawal reasons (meta_prn.choices.py)
- add EndOfStudyPhaseThreeForm, EndOfStudyPhaseThreeFormValidator
- add last_seen_date, clinical_withdrawal_reason,
toxicity_withdrawal_reason to EoS model
- refactor eligibility classes - part 1,2,3
- add fasting_opinion question to glucose
- PartFourFieldsModelMixin
- ask "Was the subject enrolled in the META Phase 2 trial?" (part_one_fields_model_mixin.py)
- remove oxygen_saturation
- import from edc_qol
- add to patient history: previous_arv_regimen_start_date
- fix pdf report - point to FollowupVitals.weight (meta_reports)

0.1.75

------
- bump edc to 0.3.50
- add euro-qol eq5d3l at 2 week visit
- empty models for study medication and concomitant medication

0.1.74

------
- bump up edc to 0.3.49

Page 7 of 10

© 2024 Safety CLI Cybersecurity Inc. All Rights Reserved.